Prio Wealth Limited Partnership’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$49.7M Sell
306,713
-675
-0.2% -$108K 1.46% 19
2024
Q2
$44.9M Sell
307,388
-40,690
-12% -$6.05M 1.34% 20
2024
Q1
$55.1M Buy
348,078
+36,506
+12% +$5.81M 1.59% 19
2023
Q4
$48.8M Sell
311,572
-3,605
-1% -$553K 1.68% 16
2023
Q3
$49.1M Sell
315,177
-7,111
-2% -$1.17M 1.89% 13
2023
Q2
$53.3M Buy
322,288
+4,749
+1% +$766K 1.91% 13
2023
Q1
$49.2M Sell
317,539
-5,226
-2% -$844K 1.89% 15
2022
Q4
$57M Buy
322,765
+2,256
+0.7% +$390K 2.29% 9
2022
Q3
$52.4M Buy
320,509
+1,596
+0.5% +$270K 2.24% 10
2022
Q2
$56.6M Buy
318,913
+653
+0.2% +$116K 2.26% 11
2022
Q1
$56.4M Buy
318,260
+3,120
+1% +$531K 1.86% 13
2021
Q4
$53.9M Buy
315,140
+1,461
+0.5% +$239K 1.65% 17
2021
Q3
$50.7M Buy
313,679
+7,583
+2% +$1.29M 1.71% 16
2021
Q2
$50.4M Sell
306,096
-434
-0.1% -$71.8K 1.7% 16
2021
Q1
$50.4M Buy
306,530
+19,548
+7% +$3.16M 1.82% 18
2020
Q4
$45.2M Buy
286,982
+6,249
+2% +$922K 1.7% 18
2020
Q3
$41.8M Buy
280,733
+20,581
+8% +$3.05M 1.74% 16
2020
Q2
$36.6M Buy
260,152
+5,442
+2% +$793K 1.69% 17
2020
Q1
$33.4M Sell
254,710
-2,028
-0.8% -$288K 1.84% 16
2019
Q4
$37.5M Buy
256,738
+3,673
+1% +$498K 1.59% 21
2019
Q3
$32.7M Sell
253,065
-2,643
-1% -$348K 1.5% 23
2019
Q2
$35.6M Sell
255,708
-1,654
-0.6% -$229K 1.64% 21
2019
Q1
$36M Sell
257,362
-5,746
-2% -$770K 1.69% 20
2018
Q4
$34M Sell
263,108
-3,917
-1% -$546K 1.81% 18
2018
Q3
$36.9M Buy
267,025
+1,167
+0.4% +$155K 1.68% 20
2018
Q2
$32.3M Sell
265,858
-5,076
-2% -$633K 1.59% 21
2018
Q1
$34.7M Sell
270,934
-11,675
-4% -$1.58M 1.73% 19
2017
Q4
$39.5M Sell
282,609
-5,628
-2% -$784K 1.84% 18
2017
Q3
$37.5M Sell
288,237
-3,017
-1% -$400K 1.83% 16
2017
Q2
$38.5M Buy
291,254
+529
+0.2% +$67.5K 1.92% 15
2017
Q1
$36.2M Sell
290,725
-2,442
-0.8% -$292K 1.86% 16
2016
Q4
$33.8M Sell
293,167
-1,240
-0.4% -$143K 1.81% 16
2016
Q3
$34.8M Sell
294,407
-4,843
-2% -$588K 1.85% 13
2016
Q2
$36.3M Sell
299,250
-2,126
-0.7% -$242K 1.99% 11
2016
Q1
$32.6M Sell
301,376
-2,358
-0.8% -$244K 1.78% 13
2015
Q4
$31.2M Sell
303,734
-13,139
-4% -$1.32M 1.71% 18
2015
Q3
$29.6M Sell
316,873
-4,144
-1% -$401K 1.68% 17
2015
Q2
$31.3M Sell
321,017
-80,911
-20% -$8.1M 1.61% 17
2015
Q1
$40.4M Buy
401,928
+1,746
+0.4% +$178K 2% 10
2014
Q4
$41.8M Buy
400,182
+6,121
+2% +$645K 2.09% 10
2014
Q3
$42M Buy
394,061
+10,748
+3% +$1.11M 2.17% 9
2014
Q2
$40.1M Sell
383,313
-16,786
-4% -$1.7M 2.02% 10
2014
Q1
$39.3M Buy
400,099
+2,069
+0.5% +$192K 1.99% 11
2013
Q4
$36.5M Buy
398,030
+8,157
+2% +$752K 1.84% 10
2013
Q3
$33.8M Sell
389,873
-3,531
-0.9% -$317K 1.92% 10
2013
Q2
$33.8M Buy
+393,404
New +$33.4M 2.03% 9

Other funds holding JNJ

Prio Wealth Limited Partnership's JNJ Position: Q3 2024 in Review

Prio Wealth Limited Partnership reduced its Johnson & Johnson (JNJ) stake by 0.22% in Q3 2024, selling an estimated $108K and leaving 306,713 shares worth $49.7M. The position accounts for 1.46% of the portfolio, ranked #19.

Prio Wealth Limited Partnership first reported a position in JNJ in Q2 2013 and has held it in 46 quarters since. The position peaked at $57M in Q4 2022. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Prio Wealth Limited Partnership held 306,713 shares of Johnson & Johnson worth $49.7M as of Q3 2024.
  • Prio Wealth Limited Partnership sold 675 Johnson & Johnson shares in Q3 2024, an estimated $108K.
  • Johnson & Johnson made up 1.46% of Prio Wealth Limited Partnership's portfolio in Q3 2024, its #19 holding.
  • Prio Wealth Limited Partnership first reported a position in Johnson & Johnson in Q2 2013 and has held it in 46 quarters since.
  • Prio Wealth Limited Partnership's Johnson & Johnson position peaked at $57M in Q4 2022.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Prio Wealth Limited Partnership's 13F filing for Q3 2024, filed 21 Oct 2024.